Results 261 to 270 of about 5,306,132 (358)

Controlling biological deterioration of wood with volatile chemicals. Interim report 1, January 1974--December 1976

, 1977
R. D. Graham, Malcolm E. Corden
openalex   +2 more sources

Exploiting Plant-Natural Enemy Interactions: Selection and Evaluation of Plants for the Improvement of Biological Control. [PDF]

Insects
Cortez-Madrigal H.
europepmc   +1 more source

YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma

Molecular Oncology, EarlyView.
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy, Samuel Hartzler, Paula A. Vargas Carranza, Shyaman Jayasundara, Madison E. Yates, Nimod D. Janson, Bozhi Liu, Annaleigh Benton, Majid Kazemian, Jason A. Hanna   +9 more
wiley   +1 more source

Bioprospecting of four Beauveria bassiana strains and their potential as biological control agents for Anastrepha ludens Loew 1873 (Diptera: Tephritidae). [PDF]

PLoS One
Angel-Ruiz NA, Zavala-Izquierdo I, Pérez-Staples D, Díaz-Fleisher F, Andrade-Torres A, Guillén-Navarro GK, Colunga-Salas P.   +6 more
europepmc   +1 more source

Emerging role of ARHGAP29 in melanoma cell phenotype switching

Molecular Oncology, EarlyView.
This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster, Melanie Kappelmann‐Fenzl, Anja Katrin Bosserhoff, Nicole Rachinger   +3 more
wiley   +1 more source

Metarhizium mendonceae sp. nov.: An important biological control agent for insect pests. [PDF]

PLoS One
da Costa Silva JD, Silva PRR, de França SM, Saleh IA, de Alcântara Neto F, El-Tayeb MA, Matos KDS, Abdel-Maksoud MA, Guimarães SDSC, Zuffo AM, da Silva GF, de Farias ARG, Briozo MEO, AbdElgawad H, de Melo MP.   +14 more
europepmc   +1 more source

Tumor‐agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell‐free DNA fragmentomics

Molecular Oncology, EarlyView.
We evaluated circulating tumor DNA (ctDNA) detection in advanced pancreatic cancer using DNA methylation, cell‐free DNA fragment lengths, and 5′ end motifs. Machine learning models were trained to estimate ctDNA levels from each feature and their combination.
Morten Lapin, Kjersti Tjensvoll, Karin Hestnes Edland, Satu Oltedal, Herish Garresori, Bjørnar Gilje, Saga Ekedal, Trygve Eftestøl, Jan Terje Kvaløy, Filip Janku, Oddmund Nordgård   +10 more
wiley   +1 more source

Nanocarrier-mediated transdermal delivery of Lmidgf4 dsRNA expedites biological control of locusts by Beauveria bassiana. [PDF]

J Nanobiotechnology
Kong X, Tan S, Guan M, Lin X, Shen J, Shi W, Wang D.   +6 more
europepmc   +1 more source

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

Molecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern, Kristian Holm, Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Corinna Bang, Bjørn Naume, Johannes R. Hov, Jon Amund Kyte   +7 more
wiley   +1 more source